JP2025513031A5 - - Google Patents
Info
- Publication number
- JP2025513031A5 JP2025513031A5 JP2024559705A JP2024559705A JP2025513031A5 JP 2025513031 A5 JP2025513031 A5 JP 2025513031A5 JP 2024559705 A JP2024559705 A JP 2024559705A JP 2024559705 A JP2024559705 A JP 2024559705A JP 2025513031 A5 JP2025513031 A5 JP 2025513031A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- groups
- cyclic hydrocarbon
- alkyl
- alkylene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210401425.8 | 2022-04-15 | ||
| CN202210401425 | 2022-04-15 | ||
| PCT/CN2023/088285 WO2023198172A1 (zh) | 2022-04-15 | 2023-04-14 | 噁二唑化合物、包含其的药物组合物及其用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025513031A JP2025513031A (ja) | 2025-04-22 |
| JP2025513031A5 true JP2025513031A5 (enExample) | 2026-04-21 |
Family
ID=88329075
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024559705A Pending JP2025513031A (ja) | 2022-04-15 | 2023-04-14 | オキサジアゾール化合物、それを含む医薬組成物及びその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250257060A1 (enExample) |
| EP (1) | EP4509506A4 (enExample) |
| JP (1) | JP2025513031A (enExample) |
| KR (1) | KR20250003703A (enExample) |
| CN (1) | CN119032089A (enExample) |
| AU (1) | AU2023254010A1 (enExample) |
| CA (1) | CA3247934A1 (enExample) |
| IL (1) | IL316301A (enExample) |
| TW (1) | TW202400147A (enExample) |
| WO (1) | WO2023198172A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2023250964A1 (en) | 2022-04-08 | 2024-11-07 | Eikonizo Therapeutics, Inc. | Oxadiazole hdac6 inhibitors and uses thereof |
| CN121969616A (zh) * | 2023-09-28 | 2026-05-01 | 勤浩医药(苏州)股份有限公司 | 一种hdac6抑制剂的结晶形式及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10357493B2 (en) * | 2017-03-10 | 2019-07-23 | Selenity Therapeutics (Bermuda), Ltd. | Metalloenzyme inhibitor compounds |
| US10435399B2 (en) * | 2017-07-31 | 2019-10-08 | Takeda Pharmaceutical Company Limited | HDAC6 inhibitory heterocyclic compound |
| EP3919055A4 (en) * | 2019-01-30 | 2022-11-09 | Takeda Pharmaceutical Company Limited | HETEROCYCLIC COMPOUND |
| CN114846012B (zh) * | 2019-09-27 | 2024-01-26 | 武田药品工业株式会社 | 可用作hdac6抑制剂的2-异吲哚-1,3,4-噁二唑衍生物 |
| BR112022025692A2 (pt) * | 2020-06-19 | 2023-02-28 | Bayer Ag | 1,3,4-oxadiazóis e seus derivados como fungicidas |
-
2023
- 2023-04-14 EP EP23787814.5A patent/EP4509506A4/en active Pending
- 2023-04-14 JP JP2024559705A patent/JP2025513031A/ja active Pending
- 2023-04-14 AU AU2023254010A patent/AU2023254010A1/en active Pending
- 2023-04-14 KR KR1020247036970A patent/KR20250003703A/ko active Pending
- 2023-04-14 WO PCT/CN2023/088285 patent/WO2023198172A1/zh not_active Ceased
- 2023-04-14 CN CN202380033896.0A patent/CN119032089A/zh active Pending
- 2023-04-14 US US18/856,846 patent/US20250257060A1/en active Pending
- 2023-04-14 TW TW112114047A patent/TW202400147A/zh unknown
- 2023-04-14 IL IL316301A patent/IL316301A/en unknown
- 2023-04-14 CA CA3247934A patent/CA3247934A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4001276B1 (en) | Aurora kinase inhibitor and use thereof | |
| JP2021522206A5 (enExample) | ||
| JP2019519476A5 (enExample) | ||
| JP2017501234A5 (enExample) | ||
| JP2013542994A5 (enExample) | ||
| JP2009539848A5 (enExample) | ||
| IL302997B2 (en) | Purine inhibitors | |
| JP2012520324A5 (enExample) | ||
| AU2015315687B2 (en) | P2X7 modulators | |
| AU2015414743B2 (en) | Process for the preparation of kinase inhibitors and intermediates thereof | |
| JP2015502387A5 (enExample) | ||
| JP2025516367A (ja) | Ｐａｒｐ１を選択的に阻害するフルオロキノキサリノン誘導体 | |
| JP2009534407A5 (enExample) | ||
| JP2023533203A5 (enExample) | ||
| JP2017508733A5 (enExample) | ||
| WO2004007471A1 (ja) | Ｎ−フェニル−（２ｒ，５ｓ）ジメチルピペラジン誘導体 | |
| JP2023543254A5 (enExample) | ||
| JP2025514382A5 (enExample) | ||
| JP2012524107A5 (enExample) | ||
| EA031614B1 (ru) | Трициклические атропоизомерные соединения | |
| JP2017516785A5 (enExample) | ||
| JP2019510801A5 (enExample) | ||
| JP2024511389A5 (enExample) | ||
| BR112021003026A2 (pt) | imidazo[1,2-b]piridazinas como inibidores de trk | |
| KR102295416B1 (ko) | 1-(피페라진-1-일)-2-([1,2,4]트리아졸-1-일)-에타논 유도체 |